Final, 5-year data from iFR-SWEDEHEART, a Swedish registry-based RCT, confirm the continued safety and efficacy of using instantaneous wave-free ratio (iFR) compared with fractional flow reserve (FFR) ...
WASHINGTON, DC (UPDATED)—Two late-breaking trials with a combined total of 4,500 patients are making the case for instantaneous wave-free ratio (iFR) measurement to guide decisions on whether or not ...
Safety of Philips’ iFR in the guidance of percutaneous coronary intervention (PCI) for heart disease demonstrated in late-breaking science at TCT 2023 highlighting patient-level outcomes analysis of ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — At 1 year, rates of MACE in patients who underwent revascularization guided by instantaneous ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Among patients who had invasive coronary angiography and physiological assessments for at least ...
PARIS — New findings from the controversial ORBITA trial provide a lift for percutaneous coronary intervention (PCI) in stable angina but also mixed results for the predictive power of fractional flow ...
SAN FRANCISCO, CA — Two new studies presented today at TCT 2013 highlight the benefit of assessing the functional severity of the coronary lesion using new twists on measuring fractional flow reserve ...
The instantaneous wave-free ratio (iFR) remained comparable to fractional flow reserve (FFR) as a tool to help decide whether patients with stable angina or acute coronary syndrome need ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the latest results demonstrating the safety of Philips instant wave-free ratio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results